SAPONARO, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 3.776
EU - Europa 3.015
AS - Asia 1.421
SA - Sud America 296
Continente sconosciuto - Info sul continente non disponibili 57
AF - Africa 37
OC - Oceania 4
Totale 8.606
Nazione #
US - Stati Uniti d'America 3.687
FI - Finlandia 1.929
SG - Singapore 429
CN - Cina 402
DE - Germania 249
BR - Brasile 240
IT - Italia 223
VN - Vietnam 204
PL - Polonia 162
HK - Hong Kong 112
TR - Turchia 101
GB - Regno Unito 87
UA - Ucraina 86
SE - Svezia 83
CA - Canada 57
RU - Federazione Russa 55
FR - Francia 48
IN - India 40
BD - Bangladesh 27
JP - Giappone 22
AR - Argentina 21
BE - Belgio 21
ZA - Sudafrica 21
MX - Messico 19
ID - Indonesia 18
IQ - Iraq 16
ES - Italia 15
NL - Olanda 15
CO - Colombia 10
AT - Austria 9
EC - Ecuador 9
CZ - Repubblica Ceca 7
PK - Pakistan 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
UY - Uruguay 5
AU - Australia 4
CL - Cile 4
KR - Corea 4
TN - Tunisia 4
TW - Taiwan 4
BG - Bulgaria 3
CR - Costa Rica 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
LT - Lituania 3
SA - Arabia Saudita 3
TH - Thailandia 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
EU - Europa 2
GR - Grecia 2
IE - Irlanda 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
MY - Malesia 2
PH - Filippine 2
PY - Paraguay 2
VE - Venezuela 2
AL - Albania 1
BB - Barbados 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GL - Groenlandia 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 8.551
Città #
Helsinki 1.884
Dallas 763
Ashburn 376
Singapore 289
Fairfield 279
Woodbridge 268
San Jose 172
Warsaw 160
Houston 140
Ann Arbor 135
Beijing 134
Wilmington 117
Santa Clara 115
Chandler 112
Hong Kong 107
Jacksonville 103
Seattle 102
Cambridge 91
Ferrara 86
Munich 67
Council Bluffs 59
New York 59
Los Angeles 58
Ho Chi Minh City 48
Hanoi 47
Izmir 38
Shanghai 33
Nanjing 32
Dong Ket 28
Milan 26
Boardman 24
Princeton 24
São Paulo 23
Turku 23
Brussels 21
Lauterbourg 21
Orem 21
Tokyo 20
Montreal 17
San Diego 17
Toronto 16
Buffalo 13
Phoenix 12
Shenyang 12
Amsterdam 11
Frankfurt am Main 11
Baghdad 10
Chicago 10
Denver 10
London 10
Stockholm 10
Atlanta 9
Brasília 9
Changsha 9
Da Nang 8
Hebei 8
Jiaxing 8
Mexico City 8
Mumbai 8
Redwood City 8
Rome 8
Tianjin 8
Addison 7
Ankara 7
Bremen 7
Brooklyn 7
Guangzhou 7
Haiphong 7
Johannesburg 7
Mcallen 7
Nanchang 7
Poplar 7
Des Moines 6
Hefei 6
Hải Dương 6
Jakarta 6
Montréal 6
Auburn Hills 5
Bari 5
Belo Horizonte 5
Biên Hòa 5
Brno 5
Chennai 5
Curitiba 5
Falls Church 5
Montevideo 5
Moscow 5
Querétaro 5
San Mateo 5
Tashkent 5
Thái Nguyên 5
Zhengzhou 5
Boston 4
Cagliari 4
Cotia 4
Guarulhos 4
Istanbul 4
Jinan 4
Manchester 4
Mountain View 4
Totale 6.562
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.124
Design and Synthesis of New A2A and A3 Adenosine Receptors Antagonists 406
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 317
A3 adenosine receptor antagonists: History and future perspectives 298
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 286
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 274
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 262
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 254
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 249
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 236
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 231
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 220
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 213
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 208
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 163
Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy 150
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists 149
Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists 143
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. 141
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors 133
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists 130
null 124
null 121
null 118
null 107
null 103
Synthesis and Biological Evaluation of Novel 2-Amino-3-Aroyl-4-Neopentyl-5-Substituted Thiophene Derivatives as Allosteric Enhancers of the A1 Adenosine Receptor 101
null 96
null 84
null 83
Transient receptor potential ankyrin 1 (TRPA1) antagonists 82
Totale 8.606
Categoria #
all - tutte 25.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.116
Totale 26.417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022284 0 0 31 15 28 18 15 15 22 33 23 84
2022/2023286 29 37 4 39 37 40 22 16 37 1 12 12
2023/2024216 17 16 8 5 22 42 6 33 2 6 5 54
2024/2025773 23 42 63 39 72 77 53 47 95 46 109 107
2025/20264.528 211 261 708 256 304 154 208 101 2.016 195 90 24
2026/2027311 143 106 62 0 0 0 0 0 0 0 0 0
Totale 8.606